Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) S&P 500
5,308.13 +4.86 (+0.09%) Dow
39,806.77 -196.82 (-0.49%) Nasdaq
16,794.88 +108.91 (+0.65%) Bitcoin USD
70,974.48 +3,815.90 (+5.68%) CMC Crypto 200
1,532.75 +44.21 (+2.97%)
Sutro Biopharma, Inc. (STRO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 4.0100 |
| Open | 4.6100 |
| Bid | 4.6200 x 100 |
| Ask | 4.6900 x 200 |
| Day's range | 4.3705 - 5.0895 |
| 52-week range | 2.0100 - 6.1300 |
| Volume | |
| Avg. volume | 1,028,548 |
| Market cap | 382.797M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
Sutro Biopharma (STRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...
- Zacks
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
© 2024 Yahoo. All rights reserved.